These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Echevarría JM; León P; Domingo CJ; López JA; Elola C; Madurga M; Salmerón F; Yap PL; Daub J; Simmonds P Transfusion; 1996 Aug; 36(8):725-30. PubMed ID: 8780668 [TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052 [TBL] [Abstract][Full Text] [Related]
12. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. Chung RT; Andersen J; Volberding P; Robbins GK; Liu T; Sherman KE; Peters MG; Koziel MJ; Bhan AK; Alston B; Colquhoun D; Nevin T; Harb G; van der Horst C; N Engl J Med; 2004 Jul; 351(5):451-9. PubMed ID: 15282352 [TBL] [Abstract][Full Text] [Related]
13. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016 [TBL] [Abstract][Full Text] [Related]
14. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT; N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351 [TBL] [Abstract][Full Text] [Related]
15. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. Genesca J; Esteban JI; Quer J; Viladomiu LL; Gonzalez A; Esteban R; Guardia J Gut; 1993; 34(2 Suppl):S62-3. PubMed ID: 7686120 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users. Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C. Morton TA; Kelen GD Ann Emerg Med; 1998 Mar; 31(3):381-90. PubMed ID: 9506498 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience. Björkander J; Fasth A; Widell A Clin Ther; 1996; 18 Suppl B():73-82. PubMed ID: 8930444 [TBL] [Abstract][Full Text] [Related]
20. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]